MXCT Long Call Strategy

MXCT (MaxCyte, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products consists of ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. It also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.

MXCT (MaxCyte, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $132.8M, a beta of 1.67 versus the broader market, a 52-week range of 0.643-2.37, average daily share volume of 1.2M, a public-listing history dating back to 2021, approximately 91 full-time employees. These structural characteristics shape how MXCT stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 1.67 indicates MXCT has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.

What is a long call on MXCT?

A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.

Current MXCT snapshot

As of June 30, 2026, spot at $1.23, ATM IV 256.50%, IV rank 51.11%, expected move 73.54%. The long call on MXCT below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.

Why this long call structure on MXCT specifically: MXCT IV at 256.50% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 73.54% (roughly $0.90 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated MXCT expiries trade a higher absolute premium for lower per-day decay. Position sizing on MXCT should anchor to the underlying notional of $1.23 per share and to the trader's directional view on MXCT stock.

MXCT long call setup

The MXCT long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With MXCT near $1.23, the first option leg uses a $1.23 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed MXCT chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 MXCT shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Buy 1Call$1.23N/A

MXCT long call risk and reward

Net Premium / Debit
N/A
Max Profit (per contract)
Unbounded
Max Loss (per contract)
Unbounded
Breakeven(s)
None on modeled curve
Risk / Reward Ratio
N/A

Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.

MXCT long call payoff curve

Modeled P&L at expiration across a range of underlying prices for the long call on MXCT. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

When traders use long call on MXCT

Long calls on MXCT express a bullish thesis with defined risk; traders use them ahead of MXCT catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.

MXCT thesis for this long call

The market-implied 1-standard-deviation range for MXCT extends from approximately $0.33 on the downside to $2.13 on the upside. A MXCT long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current MXCT IV rank near 51.11% is mid-range against its 1-year distribution, so the IV signal is neutral; the long call thesis on MXCT should anchor more to the directional view and the expected-move geometry. As a Healthcare name, MXCT options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to MXCT-specific events.

MXCT long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. MXCT positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move MXCT alongside the broader basket even when MXCT-specific fundamentals are unchanged. Long-premium structures like a long call on MXCT are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current MXCT chain quotes before placing a trade.

Frequently asked questions

What is a long call on MXCT?
A long call on MXCT is the long call strategy applied to MXCT (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With MXCT stock trading near $1.23, the strikes shown on this page are snapped to the nearest listed MXCT chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are MXCT long call max profit and max loss calculated?
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the MXCT long call priced from the end-of-day chain at a 30-day expiry (ATM IV 256.50%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a MXCT long call?
The breakeven for the MXCT long call priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current MXCT market-implied 1-standard-deviation expected move is approximately 73.54%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a long call on MXCT?
Long calls on MXCT express a bullish thesis with defined risk; traders use them ahead of MXCT catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
How does current MXCT implied volatility affect this long call?
MXCT ATM IV is at 256.50% with IV rank near 51.11%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.

Related MXCT analysis